Of course, it is necessary to indicate that BRCA1/2-mutant patients in this study are derived from the gene mutations detection of TCGA cancer patients, who are not distinguished between somatic mutations and germline mutations (not necessarily as hereditary breast cancer patients). This evidence concerns the gene BRCA1 and breast cancer.